Calendar Oramed Pharmaceuticals Inc.

Equities

ORMP

US68403P2039

Market Closed - Nasdaq 04:30:01 2024-03-28 pm EDT 5-day change 1st Jan Change
2.92 USD +3.55% Intraday chart for Oramed Pharmaceuticals Inc. -1.35% +26.41%

Chart calendar Oramed Pharmaceuticals Inc.

0d11de014727288d7020eb.FTw6B5bErtjEBcg4wPS6VcqMnC01Ef58HggcS39Yiz8.IW5Oc_295beAX7t38ZPbZJzLz194fZNFUz9IOhBq3lVfe2838LODgqlEqw~e8389626e7700c7e84a721266dda6caa

Upcoming events on Oramed Pharmaceuticals Inc.

2024-07-09 Q3 2024 Earnings Release (Projected)

Past events on Oramed Pharmaceuticals Inc.

2023-07-13 09:00 am Annual General Meeting
2023-06-23 06:15 pm American Diabetes Association Scientific Session
2023-05-31 01:30 pm Novel Therapies for Diabetes & Obesity Summit
2023-05-10 Q1 2023 Earnings Release
2022-12-07 01:30 pm Planet MicroCap Showcase
2022-11-17 11:00 am ORMD-0801 Phase 2 Trial Results Call
2022-11-10 04:30 pm Q3 2022 Earnings Release
2022-09-13 03:00 pm H.C. Wainwright Global Investment Conference
2022-08-10 04:30 pm Canaccord Growth Conference
2022-06-30 09:00 am Annual General Meeting
2022-05-25 12:00 pm H.C. Wainwright Global Life Sciences Investment Conference
2022-03-30 12:00 pm Investor Meeting - Key Opinion Leader
2022-03-15 03:50 pm Barclays Global Healthcare Conference
2022-02-24 09:30 am Aegis Capital Virtual Summit
2022-01-04 LifeSci Partners Corporate Access Event
2021-11-24 FY 2021 Earnings Release
2021-11-18 11:00 am Oravax Medical Inc and Genomma Lab 50/50 Joint Venture Agreement Call
2021-11-15 11:30 am H.C. Wainwright Israel Conference
2021-09-30 12:00 pm Cantor Fitzgerald Global Healthcare Conference
2021-09-13 07:00 am H.C. Wainwright Global Investment Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
2,70
2,70
0.22%
2,71
3,96
-31.48%
0,90


2,70
2,76
-2.24%
1,34
1,32
1.52%

1,30

EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00


0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-14,6
-16,7
12.58%
-11,8
-16,9
30.42%
0,00


-40,6
-40,1
-1.13%
-15,8
-15,7
-0.15%

-20,3

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-14,1
-16,0
12.1%
-11,5
-11,9
3.53%
0,00


-37,7
-37,7
0.05%
5,09
-10,2
149.86%

-11,3

Net income
Million USD
Released
Forecast
Spread
-14,4
-15,8
9.23%
-11,5
-11,9
3.53%
0,00


-36,6
-37,1
1.39%
5,53
-12,8
143.15%

-10,8

EPS
USD
Released
Forecast
Spread
-0,82
-0,90
8.89%
-0,56
-0,58
4%
-0,31


-0,94
-0,95
1.26%
0,14
-0,32
144.44%

-0,26

Announcement Date27/11/1924/11/2030/03/2206/03/2306/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales
Million USD
Released
Forecast
Spread
0,67
0,70
-4.86%
0,67
0,70
-3.71%
0,68
0,69
-1.52%
0,68
0,71
-4.64%
0,67
0,73
-9.18%
0,67
0,70
-3.71%
0,00
0,70
-
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-11,3
-11,0
-2.29%
-11,4
-9,60
-18.93%
-8,19
-9,57
14.46%
-9,74
-9,98
2.4%
-5,21
-10,9
52.22%
-3,79
-4,67
18.76%
-2,89
-3,85
24.86%
-3,88
-3,85
-0.7%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-10,7
-10,8
0.85%
-11,1
-9,50
-16.49%
-7,15
-10,4
31.18%
-8,74
-10,00
12.6%
-3,61
-10,1
64.25%
-1,31
-4,00
67.18%
-3,28
-3,55
7.49%
13,3
-2,00
764.8%
Net income
Million USD
Released
Forecast
Spread
-10,4
-10,8
3.47%
-10,5
-9,50
-10.87%
-7,06
-9,87
28.44%
-8,54
-9,48
9.87%
-3,40
-10,1
66.39%
-1,19
-3,93
69.64%
-3,22
-3,40
5.24%
13,3
-4,80
377.83%
EPS
USD
Released
Forecast
Spread
-0,27
-0,27
0%
-0,27
-0,25
-10.2%
-0,18
-0,25
28.95%
-0,22
-0,24
7.69%
-0,08
-0,25
67.35%
-0,03
-0,10
70%
-0,08
-0,09
7.7%
0,33
-0,12
375%
Announcement Date12/05/2210/08/2210/11/2206/03/2311/05/2310/08/2309/11/2306/03/24

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise